Agenus genital herpes vaccine succeeds in mid-stage trial
(Reuters) - Agenus Inc said a trial of its experimental genital herpes vaccine reduced the rate at which patients released the virus, reducing the likelihood of infecting others, sending its shares up 32 percent in premarket trading. (Source: Reuters: Health)
Source: Reuters: Health - November 7, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Declining HSV-1 Seroprevalence Puts Adolescents at Herpes RiskDeclining HSV-1 Seroprevalence Puts Adolescents at Herpes Risk
New data on the seroprevalence of herpes simplex viruses among U.S. adolescents suggests they face a growing risk for genital infections. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Teenagers now more likely to get genital herpes
Research published in The Journal of Infectious Diseases suggests a growing number of young people lack antibodies that may help protect them later in life. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2013 Category: Consumer Health News Source Type: news

HSV-1 Genital Herpes Increasing in Teens; polyDNA Recommends...
A new article published on LiveScience.com on October 17, 2013 said that teens may be more susceptible to infection of the genitals with HSV-1 (1). polyDNA recommends helping the immune system target...(PRWeb October 21, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11249968.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 23, 2013 Category: Pharmaceuticals Source Type: news

Increasing number of U.S. adolescents lack antibodies to herpes simplex virus type 1
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Resolve Herpes Announces New Savings on its Popular All Natural Herpes...
For a Limited Time, Customers Can Purchase the 50 Day Detox and Other Products at a Reduced Price(PRWeb October 17, 2013)Read the full story at http://www.prweb.com/releases/genital-herpes/herpes-cure/prweb11236585.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2013 Category: Pharmaceuticals Source Type: news

Today's Teens More Prone to Genital Herpes, Study Suggests
Teens today may be more susceptible to one type of genital herpes infection once they become sexually active than teens in years past, a new study suggests .In the study, adolescents ages 14 to 19 who had their blood tested between 2005 and 2010 were less likely to have antibodies against herpes simplex virus type 1(HSV-1) compared with teens who had their blood tested between 1999 and 2004. (Source: RWJF News Digest - Public Health)
Source: RWJF News Digest - Public Health - October 18, 2013 Category: American Health Source Type: news

U.S. Teens More Vulnerable to Genital Herpes, Study Suggests
They may have lower levels of protective antibodies to the virus than in years past (Source: WebMD Health)
Source: WebMD Health - October 17, 2013 Category: Consumer Health News Source Type: news

U.S. Teens More Vulnerable to Genital Herpes, Study Suggests
They may have lower levels of protective antibodies to the virus than in years past (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - October 17, 2013 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Infections, Pediatrics, Reproductive Medicine, Immunology, News, Source Type: news

U.S. Teens More Vulnerable to Genital Herpes, Study Suggests
They may have lower levels of protective antibodies to the virus than in years past Source: HealthDay Related MedlinePlus Pages: Genital Herpes, Teen Sexual Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 17, 2013 Category: Consumer Health News Source Type: news

More US teens susceptible to HSV-1 infection, a growing cause of genital herpes
(Infectious Diseases Society of America) A new study suggests a growing number of US adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. The findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than US adolescents in previous years. Without these antibodies, today's teens may be more susceptible to genital infections also caused by the virus. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 17, 2013 Category: Global & Universal Source Type: news

Uganda: Propolis Has a Load of Benefits
[Observer]Propolis obtained from beehives is touted as a treatment for numerous ailments - the common cold, peptic ulcers, coughs, tuberculosis, toothaches, cold sores (those wounds that usually "grow" at mouth corners and we attribute them to malaria), genital herpes, as well as nose and throat cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 18, 2013 Category: African Health Source Type: news

Novel vaccine reduces shedding of genital herpes virus
Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on Sept. 12. Kenneth H. Fife, M.D., is the principal investigator for the IU School of Medicine clinical study of the vaccine for herpes simplex virus type 2 called GEN-003. According to an interim analysis, the experimental protein subunit vaccine made by Genocea Biosciences of Cambridge, Mass., effectively reduces viral shedding... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 17, 2013 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news

Shingles symptoms may be caused by neuronal short circuit
The pain and itching associated with shingles and herpes may be due to the virus causing a "short circuit" in the nerve cells that reach the skin, Princeton researchers have found. This short circuit appears to cause repetitive, synchronized firing of nerve cells, the researchers reported in the journal Proceedings of the National Academy of Sciences. This cyclical firing may be the cause of the persistent itching and pain that are symptoms of oral and genital herpes as well as shingles and chicken pox, according to the researchers... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 13, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news

Novel vaccine reduces shedding of genital herpes virus
(Indiana University) Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., today, Sept. 12. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 12, 2013 Category: Global & Universal Source Type: news